The Science of Psychedelics: Training for Medical Professionals is organized by Microdose. This Conference has been approved for a maximum of 8 CME Credits.

Start Date: Feb 14, 2021
End Date: Feb 14, 2026

Course Description:
Appearing in both medical journals and pop culture magazines, psychedelic medicines are making a comeback. For the first time since the Hippie Generation, consciousness-altering substances like LSD (“acid”), psilocybin (“magic mushrooms”), MDMA (“ecstasy”), ayahuasca, iboga/ibogaine, and ketamine (“special K”) are being studied as novel breakthrough therapies for a host of mental health conditions – including treatment-resistant depression, anxiety, PTSD, social anxiety in those on the Autism spectrum, addictions (including substance use disorders), and beyond. In this workshop we will explore the emerging clinical data on these substances and consider their unique properties as powerful adjuvants to psychotherapeutic counseling. The basic (known) pharmacology of common psychedelics will be reviewed, including how they interact with antidepressants and other common medications. General guidelines for safe use – in both recreational and therapeutic settings – will also be discussed, along with the potential risks and pitfalls of using these substances. An exploration of counseling approaches that work particularly well in concert with these medicines will also be offered. As with every presentation given by Dr. Zelfand, this one promises to be packed with evidence-based information, engaging, funny, and entirely off-the-beaten-track. Note: this workshop is meant as a primer for practitioners; it is not a comprehensive training program.

 Additional details will be posted as soon as information is available.